- registered nurse practitioners, controlled substances, prescribing by - HB 321
| Advances registered nurse practitioners, controlled substances, prescribing by - SB 152 |
| Artificially provided nutrition and hydration, withholding circumstances - HB 501 |
| Assistance program, legislative study of - HCR 147 |
| Cancer drug repository, creation of - SB 23; SB 23: CCR |
| Controlled |
- substance child endangerment - SB 63; SB 63: SFA (2)
|
- substance, possession of - SB 225
|
- substances and Internet pharmacies - SB 63: HCA(1)
|
- substances, trafficking, third offense, increase penalty for - SB 155
|
| Diastat, use generic name for - SB 189: SCS |
| Drug |
- grants and funding, application for - SB 45: HCS(1)
|
- offense, possession of firearm during - SB 63; SB 63: SFA (2)
|
| Ephedrine and pseudoephedrine, restrictions on sale - SB 56; HB 170 |
| Formulary limitations, cabinet to identify special disease states that are exempt from - HB 92: HFA(1) |
| Glucagon |
- and Diastat, emergency administration at schools - HB 88: FCCR
|
- and Diastat, schools, emergency administration of - SB 189; SB 189: HCS, HFA (1); HB 184: SFA (2)
|
|
| HIV/AIDS, prescriptions, prohibition on restrictions for use of - HB 92 |
| Importation program, design and implementation of - SB 139 |
| Importation, urge the Governor to establish program to - SR 71 |
| Justice and Public Safety Cabinet, investigations - SB 45: SFA(2) |
| KADAP, prior authorization, exemption relating to - HB 92: HCS |
| Legend drug repository, creation of - SB 23: SCS |
| Marijuana possession, first offense, require jail time and fine or completion of treatment program - SB 154 |
| Medicaid, |
- pharmacy benefit manager, limitations on - SB 164
|
- repeal Drug Management Review Advisory Board related to - SB 208
|
| Methamphetamine |
- and precursors - SB 63; SB 63: SFA (1),(2),(3),(4), HFA (1),(2),(3)
|
- manufacture - SB 63: SCA(1)
|
- manufacture, intent to manufacture - SB 63: SCA(2)
|
- manufacture, possession of thirty percent of chemicals or equipment - HB 254
|
- precursors, controls on sale - HB 253
|
| Out of state pharmacies, regulation of - HB 343: HCS |
| Pharmaceutical |
- assistance program, administration of - SB 23: HCS(2), HFA (1); HB 152: SFA (3); HB 298: SFA (4)
|
- assistance program, remove redundant language related to CMS approval of - SB 23: FCCR
|
| Prescription |
- drug monitoring data, uses of - SB 176
|
- drugs, refundable tax credit for - HB 85
|
| Record of sale, electronic alternative - SB 63: CCR, FCCR |
| Repository, program providers, immunity for - SB 23: HCS(1) |
| State employee health insurance, pharmacy benefit manager, limitations on - SB 164 |
| Teachers' use or abuse, testing required - SB 220 |
| Teachers, drug testing required - SB 220: SCS |
|
